Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPACT: Metformin or Switching Antipsychotics for SGA-Induced Weight Gain in Youth
NCT00806234Phase 4Completed
- Sponsor
- Johns Hopkins University
- Start
- Jan 2009
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of metformin, aripiprazole and Perphenazine in obesity, sponsored by Johns Hopkins University. Started Jan 2009; status: completed.
02
Drugs
metforminaripiprazolePerphenazine
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00806234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00806234.